In Screening for Celiac Disease, Deamidated Gliadin Rarely Predicts Disease When Tissue Transglutaminase Is Normal
| Autor: | Natalie J. Munn, Herbert Brill, Michelle Gould, Margaret A. Marcon, Catharine M. Walsh |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
biology
business.industry Tissue transglutaminase Incidence (epidemiology) Gastroenterology nutritional and metabolic diseases Retrospective cohort study Disease Gliadin peptide digestive system diseases Serology 03 medical and health sciences 0302 clinical medicine 030225 pediatrics Pediatrics Perinatology and Child Health Immunology biology.protein Medicine 030211 gastroenterology & hepatology Antibody business Gliadin |
| Zdroj: | Journal of Pediatric Gastroenterology & Nutrition. 68:20-25 |
| ISSN: | 1536-4801 0277-2116 |
| DOI: | 10.1097/mpg.0000000000002109 |
| Popis: | Objective:While tissue transglutaminase (tTG) antibodies are the most established serological test for celiac disease, newer deamidated gliadin peptide (DGP) screening tests are increasingly being completed. No pediatric study has systematically assessed the incidence of celiac disease in pa |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text